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One of the major goals of the Great Lakes Action Plan is to actively accumulate and assess
toxicological information on persistent toxic substances found in the Great Lakes basin. As part of
Health Canada's commitment to this plan, a review of biomarkers for the environmental
contaminants polychlorinated biphenyls (PCBs) and polychlorinated dibenzodioxins/dibenzofurans
(PCDDs/PCDFs) was conducted. In general, while food consumption was identified as the major
source of human exposure to both contaminant groups, certain commodities, such as fish, milk
and dairy products, and meat, were found to predominate. Due to the ubiquitous nature of these
environmental contaminants and their propensity to bioaccumulate, all humans will have
detectable body burdens, which in certain cases can be positively associated with the consumption
of particular foods (i.e., PCBs and freshwater fish from the Great Lakes). When dealing with
environmental exposure only, relating specific effect biomarkers to contaminant exposure or
tissue levels was difficult, due in part to the complex nature of the exposure and the nonspecific
nature of the effect. For PCBs, the most likely biomarkers of effect included some form of
alteration in lipid metabolism (serum triglyceride/ cholesterol levels) and elevation of hepatic-related
enzymes, aspartate aminotransferase (AST) and y-glutamyltransferase (GGT). Cross-species
extrapolation also indicates the potential for neurotoxicologic effects to occur in humans. For
PCDDs/PCDFs, dermatologic lesions (chloracne) and indications of hepatic enzyme induction
have been documented, but primarily due to occupational or high acute accidental exposures.
Recent evidence suggests that neonates may represent a potential at-risk population due to
relatively high exposure to PCDDs/PCDFs, as with PCBs, during breast feeding as compared to
standard adult dietary intake. Future areas of potential benefit for biomarker development include
immunologic and endocrine effects, primarily based on biologic plausibility from experimental
animal research. Environ Health Perspect 103(Suppl 9):7-16 (1995)
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Introduction that have been identified in the Great Lakes
The Great Lakes Water Quality Board of basin. In a 1991 report on toxic substances
the International Joint Commission (IJC) in the Great Lakes ecosystem, the IJC stated
has developed a list of 11 critical pollutants that due to the abundance of discernable
from the nearly 400 chemical contaminants adverse health effects documented in 14
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Great Lakes wildlife species near the top of
the food chain, "the Commission must
conclude that there is a threat to the health
ofour children emanating from our expo-
sure to persistent toxic substances" (1).
As part of Health Canada's commit-
ment to the Great Lakes Action Plan, a
biomarker-related review was conducted
for three major classes of environmental
contaminants-organochlorine pesticides,
toxic metals, and halogenated aromatic
hydrocarbons-which incorporate the 11
critical pollutants. This report summarizes
the findings on polychlorinated biphenyls
(PCBs) and polychlorinated dibenzodiox-
ins and dibenzofurans (PCDDs/PCDFs).
For the purpose of this review, bio-
markers can be operationally defined as any
biologic indication that exposure to a con-
taminant(s) has taken place. Three sub-
classes of biomarkers have been suggested
(2): a) biomarkers of exposure-measure-
ment ofchemicals (including metabolites)
in body fluids, tissues, or cells or the inter-
action products between the chemicals and
an endogenous substance (Figure 1); b)
biomarkers ofeffect-morphologic, physi-
ologic, and biochemical changes that have
occurred as the result ofexposure to xeno-
biotics (depending on the dose-response
relationship, a bioeffective or critical dose
can be reached at a target organ/tissue,
resulting in an alteration of homeostasis
[compensatory responses]; when compen-
satory responses become overwhelmed,
adverse health effects may occur); and c)
biomarkers of susceptibility- any factor,
usually intrinsic or genetic, that may result
in an increased response to exposure. An
example of a biomarker ofsusceptibility in
humans is the genetic trait ofglutathione-S-
transferase (GST) deficiency. Approximately
50% of Caucasians have reduced levels of
GST, an enzyme system that assists in the
detoxification of reactive compounds, and
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Figure 1. Biomarkers of exposure. External exposure to
contaminants results in a measurable internal dose
(parent xenobiotic, metabolite, etc.).
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Figure 2. Exposure-effect continuum. Absorption, dis-
tribution, metabolism, and excretion (ADME) affects
both internal dose and bioeffective dose.
Susceptibility can effect all processes in the expo-
sure-effect continuum.
are therefore hypothesized to be at increased
risk to a variety ofgenotoxic agents (3).
Susceptibility biomarkers can be used
to explain interindividual variations seen
throughout the exposure-effect continu-
um (Figure 2).A similar encompassing
definition of biomarkers is suggested as
"any measurable chemical, biochemical,
physiological, cytological, morphological,
or other biological parameter obtainable
from human tissues, fluids, or expired
gases, that is associated (directly or indi-
rectly) with exposure to an environmental
pollutant" (4).
Halogenated Aromatic
Hydrocarbons (HAHs)
Polydchorinated Biphenyls
Polychlorinated biphenyls were first syn-
thesized in 1888 and went into full scale
production in most industrialized countries
by the 1930s. Due to their extreme heat
and chemical stability, PCBs were used in a
wide variety of applications, primarily as
dielectric fluids in transformers and capaci-
tors, lubricants, and as heat-transfer fluids.
By 1984, the total worldwide cumulative
production ofPCBs was estimated at 1.2 x
109 kg (1.3 million tons) (5) with approxi-
mately 4 x 108 kg thought to still be pre-
sent in mobile environmental reservoirs.
Although the manufacture and use of
PCBs are now severely restricted or
banned, it has been estimated that up to 8
x 106 kg may enter the environment annu-
ally through dumping, incineration, and
leakage from electrical equipment (6). In
1987 to 1988, the U.S. Environmental
Protection Agency (U.S. EPA) Toxic
Release Inventory estimated that almost
1.5 x 106 kg of PCBs were released into
the environment from accidents alone.
Commercial PCBs were manufactured
on the basis of their molecular weight and
chlorine content (21-68%) with each batch
containing a unique combination of con-
geners (isomers) distinguished by the chlo-
rine substitution pattern on two biphenyl
rings. Whereas theoretically 209 separate
congeners are possible in the commercial
mixtures, only approximately 130 are likely
to occur (7). It should also be noted that,
due to selected biodegradation processes
(e.g., reductive dechlorination, photochemi-
cal hydrolysis), environmental PCB mix-
tures differ in their congener profile from
the commercial PCB mixtures. The chemi-
cal stability of PCBs combined with their
extreme lipophilicity has led to environ-
mental persistence and bioaccumulation in
almost all ecosystem trophic levels.
The majority ofhumans are exposed to
PCBs through consumption of contami-
nated foods, particularly meat, fish, and
dairy products. In a survey offatty foods
from a Canadian dietary study (market bas-
ket), fish, particularly freshwater fish, con-
tained the highest specific PCB congener
levels (8). Market basket surveys in Ontario
have estimated that ofa total human yearly
PCB intake ofapproximately 300 pg, fresh
food accounted for 98.6%, and fish
accounted for 70%. This observation was
confirmed in a recent Finnish dietary review
in which up to 72% ofthe theoretical maxi-
mum intake of an average consumer was
attributable to fish (9). The total yearly
intake value of 300 pg/person is compar-
able to U.S. total diet studies that estimate
the average daily PCB intake as 8 ng/kg
body weight (bw) (9). A World Health
Organization review, however, indicated
that based on a 70-year lifespan, the aver-
age person would ingest a maximum of
0.2 pg/kg bw/day (10).
PCBs are effectively absorbed from the
gastrointestinal (GI) tract and respiratory
system of mammals and are then rapidly
distributed in a biphasic manner from the
blood and lymph. It has been estimated
that the GI tract absorption ofthe majority
of PCB congeners is greater than 90%
(10). In an experiment involving con-
sumption of PCB-contaminated fish by
human volunteers, serum PCB levels were
shown to rise within 4 hr after fish inges-
tion, peak by 10 hr, and return to baseline
values by 7 days (11). The magnitude of
the serum PCB increase was directly
related to the extent ofthe fish contamina-
tion. Similar investigations have shown an
increase in blood PCB levels following con-
sumption of PCB-contaminated food can
be detected as early as 2 hr postingestion
(12). Following clearance from the blood,
PCBs are primarily distributed to the liver
and lipid fractions ofvarious organs, with
liver being the main site of metabolism.
The main excretory routes for PCBs in
humans are bile and breast milk, with
additional routes including feces, hair, and
urine (minor).
Biomarkers ofExposure
Due to the ubiquitous nature of PCBs in
the environment, the majority ofhumans
will have detectable levels ofPCBs in blood,
adipose tissue, and breast milk. Based on
PCB concentrations found in domestically
produced foods, it is estimated that the gen-
eral population in North America will have
PCB whole blood values in the range of0 to
10 pg/kg (ppb) (13). In a series ofsamples
collected in 1986 to 1987 from Ontario
urban centers, 79% of 750 samples fell
within this range (mean whole blood PCB
of 9.2 ppb), indicating that the remaining
21% ofsamples (10-100 ppb) potentially
had exposure from other sources (freshwa-
ter fish consumption, occupational) (14).
The U.S. Centers for Disease Control and
Prevention (CDC) has estimated the mean
blood PCB level in the United States as 5
to 7 ppb. In a preemployment screen of a
selected nonoccupationally exposed cohort
of U.S. adults (n=738), the mean PCB
level in blood plasma was 5 ppb (15). PCB
serum levels in humans have also been
shown to increase with age, possibly in
relation to age-related increases in serum
cholesterol and triglyceride levels, and are
in general lower in females (16). Fish con-
sumption in North America has been posi-
tively correlated with blood PCB levels
(13,17). In certain species offish, the bio-
concentration factor (BCF) for PCBs has
been estimated at up to 100,000 (PCB in
fish vs PCB in water). Historically for the
Great Lakes, Lake Michigan had been asso-
ciated with some ofthe highest PCB-fish
levels. Analysis by the Michigan State
Department of Public Health has shown
that serum PCB levels in a Michigan anglers
cohort were positively correlated to history,
quantity, and type of Lake Michigan fish
consumed. People who consumed up to and
greater than 10.91 kg offish per year had
upper serum PCB ranges almost 24-fold
higher than reported fish nonconsumers
(25-366 ppb vs less than 5-41 ppb, respec-
tively) (11). In contrast, a sample of 1631
Michigan residents associated with farming
had mean (geometric) serum PCB levels of
6.3 ppb (18). There have been two major
epidemiologic episodes in which humans
have been exposed to PCBs through
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consumption offood other than fish. Over
1200 people in Japan (Yusho, 1968) and
2000 in Taiwan (Yu-Cheng, 1979) con-
sumed cooking oil contaminated with heat-
degraded PCBs, with an average estimated
PCB intake between 0.633 and 1.84 g
(157-200 pg/kg bw/day) (19). Clinical
symptoms ofintoxication, largely attribut-
able to PCDFs, polychlorinated quarter-
phenyls (PCQs), and chlorinated diphenyl
ethers, occurred by 2 to 4 months. Blood
PCB values for the Yusho subjects were
only twice that of background (6.7 ppb)
while Yu-Cheng individuals had apprecia-
bly higher levels (89.1 ppb). This is in
comparison to occupational cohorts
involved with capacitor plants and trans-
former repairs for which mean serum PCB
values ofgreater than 300 ppb have been
recorded (20).
Due to their lipophilicity, PCBs will
accumulate in organs and tissues on the
basis oflipid content. Half-lives for PCBs
in humans have been estimated at up to 4.8
years and are dependent on both the degree
of congener chlorination and the initial
serum concentration (21). Concentrations
ofPCBs in breast milk and adipose tissue in
humans are generally 100- to 200-fold
higher than PCBs in serum (10). Based on
results from the National Human Adipose
Tissue Survey in the United States, it has
been estimated that as of 1983 almost
100% of the U.S. population has
detectable adipose PCB levels (up to 1
ppm) and less than 10% have adipose PCB
levels greater than 1 ppm (22). Analysis of
108 human autopsy adipose samples from
across Canada supported the generalized
observations regarding PCB exposure bio-
markers: 100% of the samples had
detectable PCB residues with a mean level
(geometric) of 0.410 ppm (wet weight),
mean residue levels in females were approxi-
mately 20% lower than in males, and PCB
levels increased with age (the over-51-year-
old group had adipose PCB levels approxi-
mately 65% higher than the 0 to
21-year-old group [0.306 ppm vs 0.504
ppm, respectively] (23). The average con-
centration of PCBs in human breast milk
samples from industrialized countries has
been shown to be in the range of0.5 to 1.5
mg/kg milk fat or approximately 15 to 45
pg/kg of whole milk (24). Surveys of
Canadian breast milk samples for PCBs
have shown values ranging up to 1.31
mg/kg of milk fat (approximately 40
pg/kg whole milk) with a median value of
0.168 mg/kg (25). In breast milk samples
collected from Ontario residents (n=348)
between 1975 and 1985, almost 90% of
the PCB values occurred in the range of
5.1 to 50 pg/kg ofwhole milk (26).
Increased consumption of food with
high levels ofPCBs has been shown in turn
to lead to increased body burdens. In a sur-
vey of Inuit women whose diet includes
primarily native foods (marine mammals,
fresh and salt water fish), the mean whole
milk PCB level was almost 4-fold higher
than in Caucasian controls (111.3 pg/kg vs
28.4 pg/kg, respectively) (27).
Biomarkers ofEffect
Based on results in experimental animals,
the liver is thought to be the primary organ
associated with PCB effects. Observations
have included dose-dependent hepatic
enzyme induction, hypertrophy due to
smooth endoplasmic reticulum prolifera-
tion, steatosis, and necrosis. Indications of
nonspecific hepatic enzyme induction have
been seen in workers involved with capaci-
tor manufacturing. In workers with at least
4 years exposure to Aroclors (no biologic
monitoring), antipyrine half-lives (t112)
were reduced by approximately 30% com-
pared to nonexposed control workers (t1/2
10.8 vs. 15.6 hr, respectively) (28). This
confirmed previous observations of
increased antipyrine metabolism in workers
involved with pesticide manufacturing (e.g.,
DDT, lindane). Antipyrine is an analgesic
agent that in humans is completely metabo-
lized by hepatic microsomal enzymes. In a
human population exposed to PCBs
through fish consumption (serum PCB
22.2 pg/kg), plasma triglyceride and choles-
terol levels were positively correlated to
serum PCB values (13). In a cross-sectional
study of 120 male workers occupationally
exposed to PCBs through transformer
fluids, plasma PCB values, serum aspartate
aminotransferase (AST) activity, and
triglyceride levels were significantly corre-
lated (29). The mean plasma PCB value
for the most highly exposed group was
33.4 pg/kg. It was speculated that,
although there was no evidence of overt
hepatotoxicity, an interference in lipid
metabolism at the hepatic microsomal
level may have been occurring. The inci-
dence of abnormal serum triglyceride val-
ues (greater than 140 mg/dl) was also
increased in Japanese capacitor factory
workers with blood PCB levels 50 pg/kg
and greater (30). Similar indications of
physiologic effects of PCBs on the liver
were seen in a study ofworkers employed
in power capacitor plants. Serum PCB
measurements were positively correlated
with serum AST, y-glutamyltransferase
(GGT), and plasma triglyceride and high
density lipoprotein cholesterol levels (31).
PCB concentrations in worker's serum
ranged from approximately 100 to 500
ng/ml (ppb) (up to 50-fold higher than the
community background level). In a group
of 38 transformer repairmen with slightly
elevated serum PCBs (12.2 ppb, current
exposure), serum GGT activity and PCB
levels were significantly correlated in com-
parison to the control group (4.6 ppb)
(32). Based on the various epidemiologic
studies, it has been suggested that alter-
ations (outside laboratory normal range
[LNR] values) of serum AST or GGT
"appear to be the most sensitive indicators
ofPCB exposure in humans" (10,33).
In a modification of the antipyrine
assay, caffeine metabolism rates (indicative
ofhepatic CYP1A2 activity) were assessed
by the caffeine breath test in a small group
ofMichigan fisheaters (mean serum PCB
of24 vs 5.9 pg/kg in controls) (34). The
fisheaters metabolized approximately 70%
more of the administered caffeine dose
compared to the control group (4.6%/hr vs
2.7%/hr, respectively).
Indications ofthe inductive properties
ofPCBs on hepatic enzymes were also seen
in factoryworkers (n=67) involved with the
manufacturing oftransformers and capaci-
tors. With an average exposure interval of
12 years, PCB blood levels ranged from
162 to 1319 ng/ml (mean 386 ng/ml) com-
pared to up to 20 ng/ml in the controls
(n=67). Quantitative increases were seen in
the urinary excretion of porphyrin con-
geners, indicating enzymatic stimulation
and/or inhibition of the hepatic heme
biosynthetic pathway (35). The average
total urine porphyrin concentration for the
workers was 94.5 pg/l versus 48.3 pg/l in
the controls. In children transplacentally
exposed to PCBs during Yu-Cheng, total
urine porphyrin content was increased ver-
sus controls (95.2 pg/l vs 80.7 pg/l, respec-
tively) (36). No specific heme precursors
(porphyrin congeners) were measured.
A variety ofadverse reproductive effects
have been attributed to PCB exposure.
Alterations in birth weight, gestational age,
and fetal development (physical and neuro-
logic) have been assessed in infants born to
women who were either occupationally or
environmentally exposed to PCBs. In a
cohort composed ofwomen who had con-
sumed Lake Michigan fish before and dur-
ing pregnancy, mean infant birth weights
and gestational ages were reduced
(153-190 g and 4.9-8.8 days premature,
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respectively) and correlated to cord blood
PCB levels (up to 3.0 ng/ml [ppb]) (10,37).
The median maternal serum PCB level has
been estimated at up to 10.3 ppb. Missed
abortions and premature delivery have also
been associated with elevated serum concen-
trations ofPCBs and organochlorine pesti-
cides. Mean serum PCB levels were
approximately 4- to 5-fold higher in the
women (n=17) with reproductive pathol-
ogy versus the control group (103-128 vs
19.25-20.69 ng/ml, respectively) (38,39).
Appreciable levels oftotal DDT in serum
were also found in the affected women
(119.6 vs 26.5 ng/ml). In contrast to the
Michigan findings, in a cohort of 912
North Carolina infants exposed transpla-
centally to DDT and PCBs (maternal
serum PCB levels of7.0-9.1 ppb), no rela-
tionship was observed between either cont-
aminants and infant size or age (40). In
addition, it has been suggested that these
women who had consumed large quanti-
ties of Great Lakes sport fish may be a
"culturally distinct subset of the popula-
tion" and this may be associated with the
observed physical and neurological
developmental deficits (41).
In the Yusho and Yu-Cheng poisoning
episodes, the earliest toxicologic symptoms
noted were primarily dermatologic effects
(hyperpigmentation, hyperkeratosis, con-
junctivitis, chloracne). Additional general-
ized adverse health effects included
hepatomegaly, bronchitis, and peripheral
neuropathy (20). In the Yu-Cheng cohort,
increased upper respiratory tract infection
rates were associated with decreased serum
IgAand IgM plus increased IgG levels (42).
Recent reassessment of 118 children born
during and up to 6 years after Yu-Cheng
has suggested continued evidence of
delayed cognitive development (43).
However, analysis of both contaminated
rice oil mixtures fromYusho and Yu-Cheng
has determined that the primary etiological
agents responsible were not PCBs but prob-
ably PCDFs and other contaminants
(44,45). Duration ofoccupational expo-
sure to PCBs has been correlated with
increasing incidences ofchromosomal aber-
rations and sister chromatid exchanges
(SCE) detected in peripheral blood lym-
phocytes. Workers who had been employed
for 16 to 25 years (blood PCB concentra-
tions = 420 ± 220 pg/I) had a 5.85% fre-
quency ofaberrant cells and 12.6 SCE per
cell as compared to 1.60% and 6.9 SCE per
cell in a control population (blood PCB
concentrations = 3 ± 1.6 jig/l) (46).
Biomarkers ofSusceptibility
From epidemiologic investigations, it
appears that the developing fetus is at great-
est risk from PCB exposure. In the
Michigan fish eaters cohort, physiologic and
neurobehavioral deficits were noted in the
infants born to mothers who had consumed
large quantities of fish (maternal PCB
serum levels of25-366 ppb). In addition,
serum PCB levels obtained from the same
infants when they were 4 years ofage were
associated with decreases in the composite
activity ratings (infant serum PCB levels of
9-23.3 ng/ml were associated with the
largest decrease in activity) (37). In a cohort
of930 Wisconsin infants, PCB breast milk
levels of 3.5 mg/kg ofmilk fat or greater
(approximately 100 pig/kg ofwhole milk)
were associated with increased incidences of
hypotonicity and hyporeflexia (40); how-
ever, it was theorized by the authors that
the developmental or other toxic effects
noted were not attributable to breast feed-
ing but to in uteroexposure. Unlike the ori-
ental rice oil episodes, the developmental
delays observed in these infants at up to 2
years ofage were no longer evident at ages
5.5 to 10.5 years (47).
Analysis ofworkers potentially exposed
to PCBs through transformer cleanup
revealed that 8 of 16 had expression of
serum oncogene proteins (48). All liver
function tests were within the LNR while 3
workers with high serum triglycerides (>140
mg/dl) were included in the oncogene pro-
tein positive group. Only one worker had a
serum PCB value greater than 10 pg/l.
Polychlorinated Dibenzo-p-
dioxins and Dibenzofurans
Polychlorinated dibenzo-p-dioxins and
polychlorinated dibenzo-p-dibenzofurans
are two subsets ofthe halogenated aromatic
hydrocarbon (HAH) family ofubiquitous
anthropogenic environmental contami-
nants. Both groups are formed as impurities
during the synthesis ofvarious chlorinated
compounds such as chlorophenoxy herbi-
cides (e.g., Agent Orange, 2,4-dichlorophe-
noxyacetic acid), PCBs, pentachlorophenol,
and hexachlorobenzene. Significant amounts
also continue to be released into the environ-
ment through pulp and paper mill activities
and solid waste incineration (e.g., munici-
pal, hospital, hazardous) (49). It is esti-
mated that combustion ofany organic or
chlorinated material can result in the forma-
tion ofPCDDs and PCDFs (50). Analysis
ofarchived soil, vegetation, and human tis-
sue samples has revealed that the majority of
PCDDs and PCDFs have entered the
environment during the 20th century
(51,52), although detectable quantities can
still be found in biotic material from the
mid-1800s. As with PCBs, PCDDs and
PCDFs are classified according to their
chlorine substitution pattern, with a total of
75 possible PCDD congeners and 135
PCDF congeners. The 2,3,7,8 chlorine sub-
stituted PCDD/PCDF congeners (n=17)
are considered to be the most toxicologically
significant, with 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) being ofgreatest con-
cern. For risk assessment purposes, all ofthe
2,3,7,8-substituted PCDD/PCDF con-
geners are related to TCDD through the
use of toxic equivalency factors (TEFs),
numerical potency ratings developed by
international consensus (53). The concen-
tration ofeach PCDD/PCDF congener is
multiplied by its respective TEF and then
summed, giving a TCDD toxic equiva-
lency (TEQ) value. This methodology has
proven particularly useful for the determi-
nation of human body burdens because
only the 2,3,7,8-substituted congeners are
routinely detected with a high frequency in
human samples (50,54).
The chemical stability and lipophilicity
ofPCDDs/PCDFs equal or exceed that of
PCBs and, as with the majorityofHAHs, it
can be expected that these compounds will
undergo extensive biomagnification. Data
from Lake Ontario indicate that the BCF
for TCDD in some species of fish may
exceed 140,000 (55). The major route of
human exposure to PCDDs and PCDFs is
through consumption of contaminated
foods, particularly fatty foods such as meat,
dairy products, and fish. Analysis of food
groups in the Netherlands has shown that
all dairy products account for approxi-
mately 33% ofthe daily intake, fish 25%,
and other meats 17% (56). Exposure
assessment for Canadian populations also
has identified dairy products (39.7%),
meats (26.2%), and fish (12.2%) as the
principal food groups involved in human
exposure to PCDDs/PCDFs (57). PCDDs
and PCDFs have been detected in bleached
paper products (e.g., newsprint, filters,
milk cartons), suggesting migration from
packaging materials could also be consid-
ered a significant source ofexposure (58).
The possibility of occupational exposure
still exists through the accidental incinera-
tion of PCBs in transformers and capaci-
tors. Total PCDD/PCDF concentrations
in soot samples resulting from a 1981
transformer fire in Binghamton, New
York, were up to 4700 ppm, with possible
adverse human health effects attributed to
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the exposure (59). Total exposure esti-
mates for TCDD TEQs from all sources
indicate that the average daily human
intake is approximately 1 to 4.2 pg/kg bw
in industrialized countries with food
accounting for 90 to 99% (60-63).
Although consumption of contaminated
food continues to be the primary source of
human exposure to PCDDs and PCDFs, it
has recently been estimated that up to
99.9% ofthe total environmental burden
exists in soils and sediments (64).
Based on human experimental data, the
majority ofPCDDs and PCDFs ingested in
food are expected to be efficiendy absorbed
from the gastrointestinal tract. When a
human volunteer self-ingested 1.14 ng of
TCDD per ofbody weight, fecal excretion
analysis revealed that approximately 87% of
the dose was absorbed (65). Following
absorption, PCDDs/PCDFs are sequestered
to various body tissues and organs based on
lipid content. On a whole weight basis,
abdominal and subcutaneous fat contain the
greatest concentrations followed by liver,
muscle, and kidney. On a lipid basis, all
organs contained approximately the same
level of PCDDs/PCDFs (49). Available
information from most mammalian species
suggests that PCDDs/PCDFs are metabo-
lized very slowly; the major excretory routes
are feces, breast milk, and urine.
PCDDs/PCDFs have been detected in liver
samples from stillborn human infants,
which indicates that placental transfer from
mother to fetus does occur (66). The cur-
rent TCDD half-life estimation for humans
occupationally exposed (Vietnam veterans)
is up to 10 years, with shorter half-life esti-
mations for certain PCDF congeners (67).
Biomarkers ofExposure
Extensive analysis ofadipose tissue samples
from a number of countries has concluded
that almost all humans contain TCDD at
concentrations up to and greater than 3
ng/kg oflipid (ppt) (63). TCDD levels in
U.S. adipose samples ranged from 1.4 to
20.2 ppt (mean = 6.4 ppt) with 95% ofthe
levels 16.6 ppt or less. On a lipid basis, total
PCDD/PCDF concentrations are compara-
ble for adipose tissue, blood, and breast
milk with generally only the 2,3,7,8-substi-
tuted congeners being routinely detected.
Analysis of plasma and adipose samples
from the same patients has shown that, on a
lipid basis, the concentrations ofthe lower
chlorinated PCDD/PCDF congeners are
similar, but the higher chlorinated con-
geners are found at elevated levels in the
plasma samples. Based on whole blood,
PCDD/PCDF values on a lipid basis are
found at relatively equal concentrations to
adipose tissue (52). PCDDs are generally
found at higher concentrations in human
samples than PCDFs, with individual con-
geners increasing by approximately two
orders ofmagnitude on increasing chlori-
nation (tetra to octa) (65). The most
highly chlorinated PCDD congener,
octachlorodibenzodioxin (OCDD), has
been detected in Canadian adipose samples
at over 900 ppt (lipid based) while TCDD
is routinely detected in nonoccupationally
exposed individuals at 6.4 to 7.1 ppt.
Increased consumption of contaminated
food has been positively correlated with
increased concentration ofPCDDs/PCDFs
in humans. There was a consistent and sta-
tistically significant association found
between reported human fish consumption
and plasma levels ofvarious PCDD/PCDF
congeners (68). Median levels of TCDD
in plasma samples from high (1214
g/week), moderate (349 g/week), and
nonfish consumers were 8.0, 2.6, and 1.8
pg/g (ppt) ofplasma lipid, respectively. In
general, the trends for human breast milk
content ofPCDDs/PCDFs from industrial-
ized countries is similar to adipose samples;
i.e., only 2,3,7,8-chlorinated congeners are
routinely detected, PCDDs occur at greater
levels than PCDFs, the average concentra-
tion ofthe most toxic congener, TCDD, is
1 to 10 ng/kg ofmilk lipid; and the most
common congener is OCDD which occurs
at levels of 100 to 800 ng/kg ofmilk lipid
(42). Recent analysis of 100 Canadian
human milk samples supported these
observations; the concentration ofTCDD
was 2.2 ng/kg of milk lipid and OCDD
was the most abundant congener detected
(173 ng/kg of milk lipid) (69). The pri-
mary factors affecting PCDD/PCDF con-
centrations measured in nonoccupationally
exposed humans are age, diet, and body-
mass index (BMI). In U.S. adipose tissue
samples collected between 1971 and 1987,
the concentration ofTCDD increased with
respect to age; the 15- to 44-year-old age
category, TCDD adipose levels ranged
from approximately 3 to 6 pg/g oflipid
while the over-45 age category ranged from
6 to 15 pg/g oflipid (70). Humans tend to
bioaccumulate increasing levels of
PCDDs/PCDFs with respect to age, which
presumably is related to intake ofanimal
protein, fats, and fish. A direct relationship
has been established between the amount of
animal fat consumed on a daily basis and
the PCDD/PCDF content ofhuman breast
milk. Upper limits ofTCDD TEQ content
ofbreast milk samples (40 ng TEQ/kg of
milk lipid) were positively associated with
daily intake of animal fats and protein
intake ofup to 100 g (71). In addition, as
the total PCDD/PCDF intake is distrib-
uted on the basis ofbody fat content, mea-
sured congener concentrations (based on
total TEQs) have been shown to be nega-
tively associated with BMI (72).
Various cohorts have been exposed to
high levels ofPCDDs/PCDFs as the result
of the manufacture and application of
chlorophenoxy herbicides and industrial
accidents. In the large (n=5172) U.S.
National Institute for Occupational Safety
and Health (NIOSH) study (73), which
identified U.S. workers potentially exposed
to TCDD-contaminated products, the
mean serum TCDD level for all workers
measured (n=253) was 233 pg/g of lipid;
the mean level for all workers with 1 year
or more ofpotential exposure was 418 pg/g
oflipid. In comparison, a reference popula-
tion of unexposed workers had a mean
serum TCDD level of 7 pg/g of lipid.
When the latency period since the last
known exposure was taken into account
(15-37 years), the worker serum TCDD
levels, at the time of last exposure, were
estimated to be almost 3400 pg/g oflipid in
the highest exposed group or 500-fold
higher than background populations (73).
In the U.S. Air Force Ranch Hand Study,
military personnel exposed to TCDD
through pesticide application had blood
lipid TCDD levels approximately 3-fold
higher than the comparison population
(12.8 ppt vs 4.2 ppt; range to 618 ppt vs
54 ppt) (74). Current blood TCDD levels
greater than 33.3 ppt were classified as
belonging to the high exposure category. A
cohort from Seveso, Italy, exposed to
TCDD as the result ofan industrial acci-
dent, has the highest known human serum
TCDD values (75). Individuals from the
geographical zone ofhighest contamination
(soil TCDD levels up to 54 ppb) had an
average serum TCDD value of 12,558 pg/g
oflipid (range 828-56,000 pg/g).
Biomarkers ofEffect
In a recent summary ofpossible adverse
human health effects associated with
PCDD/PCDF exposure, it was concluded,
based on aweight-of-evidence classification
scheme, that there was limited to sufficient
evidence to attribute variations in serum
lipid levels, chloracne and related dermato-
logic effects, microsomal enzyme induc-
tion, and gastrointestinal alterations as
biologic effects (76).
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Chloracne and related dermatologic
effects have been described as one of the
more consistent and reproducible conse-
quences of PCDD/PCDF exposure in
humans (49,77-80). Over 465 cases of
chloracne have been documented world-
wide in workers involved with industrial
accidents during trichlorophenol produc-
tion. In the Oriental rice oil poisonings,
one of the earliest toxicologic symptoms
was mild chloracne associated with an aver-
age TCDD TEQ intake of 1.5 to 3.0
ng/kg/day for 2 to 4 months (49). Total
estimated TCDD TEQbody burdens were
150 pg or approximately 200-fold greater
than the average current level of TCDD
TEQs in North American adults (81). In
comparison, the estimated chloracne-
inducing dose in a Spanish family who
ingested PCDD/PCDF-contaminated
olive oil for approximately 6 to 7 months
was 32 to 76 ng/kg/day (82). The discrep-
ancy between the two estimated chloracne-
inducing doses may be the result of
congener patterns; in the rice oil poison-
ings, PCDFs were more prevalent, but
PCDDs were more predominant but in the
olive oil example. In addition, 8 of 10
human volunteers who had 107 pg
TCDD/kg/day applied dermally to their
backs (15 alternative day treatments) devel-
oped chloracne, which persisted for 4 to 7
months (83). Ten children from the high-
est contaminated zone of Seveso who
developed chloracne had serum TCDD
levels of828 to 56,000 ng/kg oflipid with
the average chloracne-inducing dose esti-
mated at 3.1 pg/kg. In workers involved
with 2,4,5-trichlorophenoxyacetic acid
(2,4,5-T) production, light chloracne was
evident with median blood lipid TCDD
concentrations of305 pg/g (extrapolated to
1640 pg/g at the end of exposure) (79).
The severity of chloracne and current
serum TCDD levels were closely associated
in employees of BASF chemical plants in
Germany. Individuals with severe chlo-
racne were more likely to have serum
TCDD values greater than 100 pg/g of
serum lipid (84). These values are compa-
rable to the estimated intake of 15 pg of
TCDD TEQ per kilogram per day in a
high fish consumer and blood lipid TCDD
levels ofless than 20 pg/g.
In a cross-sectional survey ofworkers
employed in U.S. Monsanto plants involved
with 2,4,5-T production, chloracne was
seen in 52% of the estimated exposed
cohort versus 0% in the unexposed cohort
(85). The mean serum GGT levels and the
incidence rate of abnormal serum GGT
values (greater than 29 International Units
[IU]) were also increased in the chloracne
group (26.3 IU, 23%) as compared to the
nonchloracne cohort (17.4 IU, 9%) (86).
Additionally, after accounting for various
confounding variables, the incidence rate
of upper GI tract ulcers continued to be
significantly elevated in the exposed chlo-
racne group versus the referent population
(16.6% vs 5.5%).Various neurologic abnor-
malities (e.g., peripheral-sensory neuropa-
thy, decreased nerve conductance velocity,
decreased libido, depression, insomnia) have
been observed in humans occupationally or
accidentally exposed to PCDDs/PCDFs. In
three chemists involvedwith the synthesis of
TCDD, decreased libido, sleeping difficul-
ties, depression, and moderate to severe
chloracne were the first symptoms noted
(49). All symptoms, with the exception of
the severe chloracne, were considered tran-
sient and disappeared within 1 to 2 years
after elimination of the exposure. Indi-
viduals exposed to PCDDs/PCDFs from
contaminated soil (originating from a metal
reclamation plant) for an average of21 years
had a higher incidence rate ofself-reported
noncognitive complaints (e.g., emotional
instability, irritability) than the control
group (87). In addition, the group with the
highest exposure estimation (residency
time) also displayed reduced cognitive per-
formance and psychomotor slowing.
Although the range of TCDD TEQs
found in the blood samples were within
the national average (16-80 ng/kg ofblood
lipid; mean value 31 ng/kg), elevated levels
of specific congeners (penta-, hexa-, and
heptachlorinated PCDDs) that were also
common to the contamination in question
were found. Screening for hepatic and gas-
trointestinal effects in the NIOSH cohort
revealed that the risk for an out-of-range
serum GGT value (GGT referent value of
96 IU/l) in those TCDD-exposed workers
who consumed alcohol increased with
increasing serum TCDD levels (odds ratio
2.27) (88). The mean GGT level was also
significantly higher in the workers versus
the control group (58.5 IU/l vs 47.4 IU/l).
Transient alterations in serum biochemistry
were also observed in children exposed to
TCDD at Seveso. In children from the geo-
graphic zone of highest TCDD fallout,
slight increases in serum alanine transferase
(ALT) and GGT were noted, primarily in
males (89). The differences were restricted
to inside the established reference limits
and were less prevalent 1 year after the acci-
dent. Additional evidence ofTCDD's abil-
ity to induce transient hepatic alterations
were seen in this study population. Urinary
D-glucaric acid excretion, an indirect indica-
tion of hepatic enzyme activity, was
increased in people living within Seveso as
compared to Cannero, a nonindustrialized
reference town (27.1 vs 19.8 pmol/g ofcrea-
tinine) (90). In children with chloracne
from the highest exposure area of Seveso,
the median concentration ofurinary D-glu-
caric acid was also elevated compared to
children without skin lesions (39 vs 20.5
pmol/g of creatinine, respectively). In four
children who were evacuated from the zone
ofcontamination, the average amount ofD-
glucaric acid excreted decreased by approxi-
mately 56% in 4 to 6 months.
Although PCDDs and PCDFs are
potent animal immunotoxicants, limited
evidence is available to support this obser-
vation in humans. In an initial study of
individuals exposed to TCDD from conta-
minated soil (average exposure time of2.8
years), the exposed group displayed an
increased frequency of anergy (11.8% vs
1.1%) and relative anergy (35.3% vs
11.8%) on skin testing compared to the
unexposed controls (91). B-lymphocyte cell
numbers were not measured, but the num-
ber of non-T peripheral lymphocytes was
increased in the exposed group by approxi-
mately 16%. However, follow-up of these
subjects 12 to 16 months later revealed no
differences in anergy or relative anergy rates
between the two groups, an observation
attributed by the authors as probably due to
weak potency of the initial skin tests (92).
Abnormal T-helper/T-suppressor (T4/T8)
ratios (less than 1.0) were found with
greater frequency in the exposed group ver-
sus the controls (4/23 vs 0/15). In the same
cohort, diminished levels of serum
Thymosinalpha-1 (Thya-1) were found in
the group presumed to be exposed to
TCDD-contaminated soil versus the unex-
posed controls (93). Ninety-four exposed
people had mean serum Thya-1 levels of
977.3 pg/ml versus 1148.7 pg/ml in the
controls. Thya-1 is a peptide produced by
the thymus gland whose function is to
modulate lymphokine expression and the
differentiation of thymocytes. Although
the biologic significance ofthe finding was
unclear, the authors suggested that some
form of mild insult may have occurred to
the thymus and lymphoid tissue, which is
consistent with the ability of TCDD to
induce thymic atrophy in the majority of
experimental animals tested (94). In a
group of89 workers involved in the decon-
tamination of a German chemical plant,
immunologic evaluations were performed,
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with intragroup comparisons based on
blood TCDD values. Low, medium, and
high level controls were defined as having
blood TCDD values between 1 and 23 ppt
(lipid based) and all persons with blood
TCDD values ofgreater than 24 ppt were
considered exposed (95). Based on experi-
mental studies with nonhuman primates,
specific cell surface receptors on lympho-
cyte subpopulations were investigated. No
differences were found between the various
subgroups in the total number of leuko-
cytes, granulocytes, or lymphocytes.
However, 33% ofboth the exposed group
(4/12) and the high level controls (10-23
ppt TCDD; 5/15) did show a trend of
increases in the percentage oflymphocyte
cells carrying the CD4 and CD45RO sur-
face receptors. In addition, 40% of the
same groups had CD19+CD20+CD21+
(mature) B-cell numbers lower than the ref-
erence population. The subtle changes
observed in the different lymphocyte sub-
populations was described as being "of no
medical relevance" (95).
Indications ofpossible endocrine altera-
tions due to TCDD exposure have been
documented in the National Institute for
Occupational Safety and Health (NIOSH)
and U.S. Air Force Ranch Hand cohorts
(75,96). Factory workers classified as dia-
betic had a mean serum TCDD level of640
ppt (ng/kg ofserum lipid) versus 170 ppt in
workers without diabetes. In the Ranch
Hand study (75), the incidence rate ofdia-
betes was elevated 2-fold in the high cur-
rent-serum dioxin group (greater than or
equal to 33 ppt) versus the comparison
group (16.6% vs 8.3%, respectively) (75).
In relation, study participants classified as
obese had a mean current-serum-dioxin
level greater than the normal/lean
classification group (22.4 ppt vs 12.9 ppt,
and 4.4 ppt vs 3.3 ppt in the controls,
respectively). The finding of low serum
testosterone (less than 10.4 nmol/l) in the
NIOSH cohort (96) was also positively
associated with serum TCDD levels. In
workers with present serum TCDD values
of greater than 241 ppt (n=61), the inci-
dence was approximately 16.4% versus
11.7% in the group with serum TCDD of
76 to 240 ppt (n=62). The referent popula-
tion (n=231) (mean serum TCDD = 6.08
ppt) prevalence rate for low serum testos-
terone was 4.8%. In addition, there was a
greater prelevance ofhigher serum luteiniz-
ing hormone (LH) values (greater than 28
IU/l) observed in the workers with serum
TCDD greater than or equal to 20 ppt and
high serum follicle-stimulating hormone
(FSH) values (greater than 31 IU/l) in
workers with serum TCDD values greater
than 241 ppt. Ofthe workers with present
serum TCDD values of 20 to 75 ppt
(n=60), 10% had high LH values versus
6.5% of the referent population (96).
Overall, Egeland et al. (96) concluded that
present serum TCDD values in the work-
ers were positively related to LH and FSH
values and inversely related to total serum
testosterone levels.
Biomarkers ofSusceptibility
It is now generally accepted that most, ifnot
all, of the toxic effects attributed to
PCDDs/PCDFs are mediated through a
cytosolic aryl hydrocarbon (Ah) receptor
(97-99). One of the initial responses
detectable following TCDD interaction with
the Ah receptor is increased enzyme activity
(cytochrome P450 lAI and 1A2 isozymes
[CYPlAI, CYP1A2]). In a method analo-
gous to steroid hormones, PCDDs/PCDFs
bind to or activate the Ah receptor, which
results in the increased transcription/transla-
tion ofAh-specific gene products (aryl
hydrocarbon hydroxylase [AHH] or the
related ethoxyresorufin- O-deethylase
[EROD] enzyme activity). Induction of
EROD activity in human lymphocytes in
vitro by TCDD showed an approximately
25-fold variation in 39 subjects (99). In
human placenta samples obtained from
women ofYu-Cheng, there was an approxi-
mate 100-fold induction ofAHH activity,
with an overall variation of up to 60-fold
(100). The magnitude ofenzyme induction
did not correlate with the measured con-
centrations ofPCBs and PCDFs in the pla-
cental samples. Induction of EROD/AHH
activity in human lymphocytes has previ-
ously been associated with increased suscep-
tibility to lung cancer in humans (101).
Recently, polymorphism in the CYPJAJ
gene locus has been shown to be correlated
with EROD induction in human lympho-
cytes (102). Heterozygosity for a particular
polymorphism (MspI) in the CYPIAI gene
was associated with significantly greater
induced EROD activity. Previously, this
same polymorphism had been linked with
increased risk for lung cancer. These exam-
ples ofhuman phenotypic/ genotypic poly-
morphisms in principle Ah receptor events
would serve to further complicate bio-
marker development and interpretation.
Increased attention has been given to the
possibility ofadverse health effects attrib-
uted to in utero and lactational exposure of
infants to PCDDs/PCDFs. PCDD/PCDF
concentrations were measured in the breast
milk of 38 Dutch mothers and related to
thyroid hormone regulation in newborns.
Infants consuming breast milk with an
average of 37.5 ng ofTCDD TEQ per
kilogram oflipid (high group) had statisti-
cally significant increases in serum thyroxin
and thyroxin/TBG (thyroid binding globu-
lin) at 1 and 11 weeks post parturition when
compared to infants who consumed breast
milk with an average of 18.6 ng ofTCDD
TEQs per kilogram oflipid (low) (103).
Thyroid stimulating hormone (TSH) was
also increased by 27% at 11 weeks ofage in
the high group. The current Canadian aver-
age breast milk TCDD TEQ is 15.6 ng of
TCDD TEQs per kilogram oflipid (n=100
from 1986-1987) (69). The authors con-
cluded that in utero and lactational exposure
to PCDDs/PCDFs is capable ofaffecting
the hypothalamic-pituitary-thyroid regula-
tory system in human infants (69). In a
similar study (104), breast milk TCDD
concentrations were related to early/late
hemorrhagic disease in newborns. In a lim-
ited sample, four mothers whose infants
developed some form ofbleeding after birth
had a mean breast milk TCDD content of
12.13 ng/kg ofmilk lipid as compared to
9.01 ng/kg in 10 mothers with asympto-
matic infants (104). Although slightly
lower, the breast milkTCDD TEQvalue of
the former group was not significantly dif-
ferent from the controls. Again, in compari-
son, the average TCDD concentration in
Canadian breast milk from 1986 to 1987
samples is 2.2 ng/kg ofmilklipid.
Summary
Biomarkers of exposure (external and
internal), effects, and susceptibility were
reviewed for PCBs and PCDDs/PCDFs;
when possible, comparisons were made to
the Great Lakes basin. After evaluation of
the available data, it can be concluded that
a variety ofconfounding factors might pre-
vent the establishment of definitive bio-
logic dose-response relationships between
external exposure/internal dose and bio-
logic effects. These factors included the
complex nature ofenvironmental contami-
nant exposure, probable exposure mis-
classification due to lack of internal
biomarkers ofexposure (in certain cases),
nonspecificity ofbiomarkers ofeffect, and
unknown or inadequately defined biomark-
ers ofsusceptibility. In two recent reviews
dealing with human exposures to PCBs, it
was concluded that there was uncertainty as
to what, ifany, PCB level in humans might
be associated with an adverse health effect
(105,106). While considerable evidence
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exists from the Oriental rice oil poisonings
that humans who have been highly exposed
to a complex mixture ofHAHs will develop
numerous adverse health effects, attempts to
identify similar effects (e.g., immunologic,
reproductive, developmental) in low or
moderately exposed cohorts have been
largelyequivocal.
In the absence ofdefinitive epidemio-
logic data, biomarkers may still assist the
health assessment process by initially
providing evidence of increased exposure
to contaminants and therefore ofpossible
increased risk. After a determination that
some facet of exposure has resulted in a
quantifiable increased body burden, research
can then focus on whether an internal bio-
logically effective dose level has also been
reached. The majority of biomarkers of
effect for PCDDs/PCDFs and PCBs that
are presently available can be described as
adaptive or as representative ofsome form
ofalteration in homeostatic function. While
current biomarker data for these two groups
ofcontaminants may not be at the interpre-
tation stage for developing risk assessment
guidelines, certain data do provide direction
for future research efforts (i.e., endocrine
effects in neonates). However, through con-
tinued characterization and validation,
earlier biomarkers ofeffect along the expo-
sure-disease continuum could eventually be
used to improve regulatory decisions regard-
ing environmental contaminant exposure
and protection ofhuman health.
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